VP, Novel Asset Advancement

Telix Pharmaceuticals Limited

VP overseeing Telix's CD66-targeted hematology-oncology programs development. Ensuring strategic alignment and resource optimization in late-stage oncology product advancement.

Posted 6/5/2026full-timeRemote • 🇺🇸 United StatesLeadWebsite

About the role

Key responsibilities & impact

Serve as the executive asset owner for Telix’s CD66-targeted hematology-oncology programs, with full accountability for end-to-end asset strategy, progression, and value realization through clinical development and toward registration.
Define and continuously evolve the integrated asset strategy, including development approach, indication prioritization, target product profile, and long-range positioning aligned to enterprise portfolio priorities.
Own the integrated business case, including financial assumptions, risk-adjusted scenarios, and value inflection points, and lead executive-level recommendations on investment, prioritization, and development pathways.
Act as the primary accountable leader in executive governance forums (e.g., GET), presenting strategic options, trade-offs, and recommendations while driving enterprise decision-making and alignment.
Operate as a peer to functional Vice Presidents, leading cross-functional alignment across Clinical, Regulatory, Manufacturing, Commercial, Finance, and Quality to ensure execution of a unified and optimized development strategy.
Drive enterprise-level trade-off decisions, balancing scientific, clinical, regulatory, operational, and financial considerations to maximize probability of success and long-term asset value.
Maintain accountability for program performance, including milestone achievement, risk profile, timeline integrity, and overall readiness for key development and regulatory inflection points.
Lead identification, evaluation, and mitigation of strategic and operational risks, ensuring proactive management and clear escalation of critical issues to executive leadership.
Provide strategic financial oversight of the program, including investment planning, scenario modeling, and alignment of resource allocation with development priorities and enterprise objectives.
Ensure consistent executive-level visibility into program status, risks, opportunities, and strategic options through structured governance and performance reviews.
Influence broader portfolio strategy and lifecycle planning, including evaluation of expansion opportunities and implications for future hematology-oncology pipeline development.
Drive a high-performance cross-functional operating model, holding stakeholders accountable for delivering against shared objectives while enabling speed, clarity, and disciplined decision-making.

Requirements

What you’ll need

Advanced degree in life sciences, medicine, pharmacy, or related field required; PhD, MD, or PharmD preferred
15+ years of progressive pharmaceutical or biotechnology experience, including significant experience in drug development and strategic program or asset leadership
Demonstrated experience leading complex, cross-functional development programs or assets, ideally within oncology
Proven ability to own and advance asset strategy, including business case development, development planning, and governance engagement
Strong understanding of global regulatory environments (FDA, EMA, APAC) and their impact on development strategy
Demonstrated success operating as a senior individual contributor influencing executive leadership and cross-functional decision-making
Experience presenting to and influencing executive governance bodies (e.g., executive committees, portfolio boards)
Strong financial and strategic acumen, including investment decision support, scenario planning, and risk management

Benefits

Comp & perks

Competitive salaries
Annual performance-based bonuses
Equity-based incentive program
Generous vacation
Paid wellness days
Support for learning and development

ATS Keywords

✓ Tailor your resume

Applicant Tracking System Keywords

Tip: use these terms in your resume and cover letter to boost ATS matches.

Hard Skills & Tools

drug developmentasset strategybusiness case developmentdevelopment planninggovernance engagementfinancial oversightscenario modelingrisk managementmilestone achievementregulatory compliance

Soft Skills

leadershipinfluencingcross-functional collaborationstrategic decision-makingcommunicationaccountabilityproblem-solvingperformance managementstakeholder managementexecutive presentation

Certifications

PhDMDPharmD